TWD 32.3
(1.1%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 4.9 Million TWD | -82.27% |
2022 | 27.69 Million TWD | 352.28% |
2021 | 6.12 Million TWD | 1968.58% |
2020 | 296 Thousand TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 FY | 4.9 Million TWD | -82.27% |
2022 FY | 27.69 Million TWD | 352.28% |
2021 FY | 6.12 Million TWD | 1968.58% |
2020 FY | 296 Thousand TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
BIONET Corp. | 78.39 Million TWD | 93.738% |
DIVA Laboratories, Ltd. | 73.61 Million TWD | 93.332% |
Genetics Generation Advancement Corp. | 28.56 Million TWD | 82.815% |
Welgene Biotech Co.,Ltd. | -2.64 Million TWD | 285.385% |
Puriblood Medical Co., Ltd. | -51.59 Million TWD | 109.514% |